SCOTT SWAIN: Open Payments
NPI 1588161590 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 10 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $99 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
Products named: UZEDY, ABILIFY ASIMTUFII, REXULTI, COBENFY.
Industry payments across TX — which companies pay providers there.
